Steriscience Specialties Private Limited Methylprednisolone Export Data — India (DGFT 2022–2026)

Name: Steriscience Specialties Private Limited Methylprednisolone Export Records India — #7 Exporter, 14 Shipments, $700.0K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Methylprednisolone

India Pharmaceutical Trade Intelligence

$29.3M355 Suppliers128 CountriesHS 30049099

ExportsIndia → UNITED STATES70.0%India → ECUADOR4.5%

ImportsITALY → India$5.2B BELGIUM → India$689.0M

#1 Supplier: PAR FORMULATIONS #1 Buyer: EVERSANA LIFE

Steriscience Specialties Private Limited — Methylprednisolone Exporter #7 | $700.0K Trade Value | TransData Nexus | TransData Nexus

Steriscience Specialties Private Limited — Methylprednisolone Exporter Profile

Indian Pharmaceutical Exporter · #7 for Methylprednisolone · $700.0K export value · DGFT Verified

Steriscience Specialties Private Limited is the #7 Indian exporter of Methylprednisolone with $700.0K in export value and 14 verified shipments. Steriscience Specialties Private Limited holds a 2.4% market share in Methylprednisolone exports across 1 countries. The company exports 4 pharmaceutical products worth $23.8M across 4 therapeutic categories.

Steriscience Specialties Private Limited — Methylprednisolone Export Profile: Buyers & Destinations

Steriscience Specialties Private Limited Methylprednisolone export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Methylprednisolone?

Country	Value	Shipments	Share
UNITED STATES	$13.7M	273	70.3%
ECUADOR	$1.3M	33	6.8%
VIETNAM	$518.8K	13	2.7%
SUDAN	$420.2K	102

Who Are the Top Buyers of Methylprednisolone from India?

Buyer	Country	Value	Orders
EVERSANA LIFE SCIENCE SERVICES	UNITED STATES	$4.4M	136
EUGIA US LLC	UNITED STATES	$1.2M	24
NUTRA MED PACKAGING INC	UNITED STATES	$850.0K	17
SAGENT PHARMACEUTICALS	UNITED STATES	$700.0K	14
EVERSANA	UNITED STATES	$650.0K	13
NUTRA MED PACKAGING LLC	UNITED STATES	$500.0K	10
EUGIA US LLC,	UNITED STATES	$400.0K	8
SHARP PACKAGING SERVICES LLC	UNITED STATES	$300.0K	6
XXNEAXXEU XXMITXX	UNITED STATES	$300.0K	6
SAGENT PHARMA	UNITED STATES	$150.0K	3

India's Methylprednisolone is purchased by 576 buyers worldwide. The top buyer is EVERSANA LIFE SCIENCE SERVICES (UNITED STATES), followed by EUGIA US LLC and NUTRA MED PACKAGING INC.

How Does Steriscience Specialties Private Limited Compare to Nearest Methylprednisolone Exporters?

Exporters ranked immediately above and below #7 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	CARITAS HEALTHCARE PRIVATE LIMITED	$1.1M	22	1	$50.0K
4	MYLAN LABORATORIES LIMITED	$800.0K	16	1	$50.0K
7	STERISCIENCE SPECIALTIES PRIVATE LIMITED ★	$700.0K	14	1	$50.0K
8	CADILA HEALTHCARE LIMITED	$650.0K	13	1	$50.0K
10	TROIKAA PHARMACEUTICALS LIMITED	$458.8K	20	3	$22.9K

Steriscience Specialties Private Limited ranks #7 among 355 Indian Methylprednisolone exporters. Average shipment value of $50.0K compared to the market average of $41.9K. The closest competitors by value are CARITAS HEALTHCARE PRIVATE LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Methylprednisolone Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	612	24.6%
SAHAR AIR	482	19.3%
Bombay Air	138	5.5%
DELHI AIR CARGO ACC (INDEL4)	119	4.8%
NHAVA SHEVA SEA (INNSA1)	113	4.5%
DELHI AIR	90	3.6%
Bombay Air Cargo	78	3.1%
AHEMDABAD AIR	77	3.1%

Geopolitical & Trade Policy Impact on Steriscience Specialties Private Limited's Methylprednisolone Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Steriscience. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per Twenty-foot Equivalent Unit (TEU). This escalation in shipping costs directly impacts the profitability of exports to Europe and the US East Coast, necessitating strategic adjustments in logistics and pricing. (sgeexport.com)

Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. However, the US's push for pharmaceutical manufacturing reshoring and the imposition of tariffs as high as 245% on Active Pharmaceutical Ingredients (APIs) have led to a complex trade environment. Indian firms have responded by investing in US facilities to circumvent these tariffs, with outbound foreign direct investment (OFDI) ranging between $500-700 million during partial FY 2025-26. (odrindia.in)

The India-European Union Free Trade Agreement (FTA), concluded on January 27, 2026, eliminates tariffs on Indian pharmaceuticals, APIs, vaccines, and medical devices entering the EU. This development offers Steriscience a competitive edge in the European market, potentially increasing export volumes and profitability. (en.wikipedia.org)

Steriscience Specialties Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The US Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practice (EU GMP) certifications are critical for market access. Steriscience's facilities, including the USFDA-approved sterile fill-finish manufacturing facility in Warsaw, Poland, and the integrated carbapenem facility in Vadodara, India, underscore the company's commitment to quality and regulatory adherence. (business-standard.com)

The evolving regulatory landscape, including the EU's Falsified Medicines Directive and the US's stringent import policies, necessitates continuous investment in compliance and quality assurance. Steriscience's proactive approach in aligning with these standards positions it favorably in the global market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Methylprednisolone shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Steriscience Specialties Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 128+ countries, 576+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Methylprednisolone

Methylprednisolone

Steriscience Specialties Private Limited — Methylprednisolone Exporter Profile

Steriscience Specialties Private Limited — Methylprednisolone Export Profile: Buyers & Destinations

Where Does India Export Methylprednisolone?

Who Are the Top Buyers of Methylprednisolone from India?

What Is India's Total Methylprednisolone Export Value and How Much Does Steriscience Specialties Private Limited Contribute?

What Is the Average Shipment Value for Steriscience Specialties Private Limited's Methylprednisolone Exports?

How Does Steriscience Specialties Private Limited Compare to Other Indian Methylprednisolone Exporters?

Regulatory Requirements: Exporting Methylprednisolone to Key Markets

United States — FDA

How Does Steriscience Specialties Private Limited Compare to Nearest Methylprednisolone Exporters?

Which Indian Ports Ship Methylprednisolone Exports?

Geopolitical & Trade Policy Impact on Steriscience Specialties Private Limited's Methylprednisolone Exports

Steriscience Specialties Private Limited — Regulatory Compliance & Quality Standards

About Steriscience Specialties Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Methylprednisolone Export Data from Steriscience Specialties Private Limited

Methylprednisolone Stats

Company Overview

Top Products by Steriscience Specialties Private Limited

Related Analysis

Need Detailed Export Data?

Data Source